DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Target & Pathway ModulatorsTarget & Pathway Modulators
  5. /Sigma ReceptorSigma Receptor
  6. /CT-1812CT-1812
Chemical structure of CAS 1802632-22-9

CT-1812

In Stock•Starting at $638 for 1 mg•Purity ≥ 97.15%
CAS No.1802632-22-9
MDL No.N/A
MFC24H33NO4S
MW431.60
InChI KeyISQAPFMBJFZOLG-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg97.15%$638In Stock
5 mg97.15%$1581In Stock
10 mg97.15%$2439In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1802632-22-9
Product NameCT-1812
Heavy Atom Count30Rotatable Bond Count6
Atom Stereo Count0Bond Stereo Count0
HBA5HBD1
TPSA66.840 ŲCharge0
Exact Mass431.21303Complexity1035.66
pKa8.400XLogP4.700

Related Articles

Studies related to this compound and its mechanism of action

The Allosteric Antagonist of the Sigma-2 Receptors-Elayta (CT1812) as a Therapeutic Candidate for Mild to Moderate Alzheimer's Disease: A Scoping Systematic Review.

Life (Basel, Switzerland) • Vol. 13, Issue 1 • 2022
PMID: 36675950PMC: PMC9866790DOI: 10.3390/life13010001

Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease.

ACS medicinal chemistry letters • Vol. 12, Issue 9 • 2021
PMID: 34531947PMC: PMC8436239DOI: 10.1021/acsmedchemlett.1c00048

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.

Alzheimer's & dementia : the journal of the Alzheimer's Association • Vol. 17, Issue 8 • 2021
PMID: 33559354PMC: PMC8349378DOI: 10.1002/alz.12302

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact